The 20 Best Heart Tumor Doctors Near Me in Maryland, US

Douglas Rosing is a Cardiologist in Bethesda, Maryland. Dr. Rosing is rated as a Distinguished provider by MediFind in the treatment of Heart Tumor. His top areas of expertise are Degos Disease, Heart Tumor, Carney Complex, and Cardiomyopathy.

Jennifer S. Lawton, M.D., is the Richard Bennett Darnall Professor of Surgery and chief of the Johns Hopkins Division of Cardiac Surgery, as well as director of the Cardiac Surgery Research Laboratory. Dr. Lawton’s clinical area of focus is adult cardiac surgery. She also leads the division’s residency education program, and conduct research in myocyte volume regulation and ATP-sensitive K channels. She has held important leadership roles in several organizations, including chair of the surgery study section of the American Heart Association, vice-chair of the ACGME residency review committee, and president of the Women in Thoracic Surgery. Lawton’s achievements also include 81 peer-review publications, 7 book chapters, and 18 abstracts. She has delivered over 50 invited lectures. Dr. Lawton is rated as an Advanced provider by MediFind in the treatment of Heart Tumor. Her top areas of expertise are Heart Tumor, Aortic Dissection, Atrial Myxoma, Heart Bypass Surgery, and Coronary Artery Bypass Graft (CABG).

Ahmet Kilic is a cardiac surgeon in Baltimore, Maryland. He is an associate professor of surgery at the Baltimore-based Johns Hopkins University School of Medicine. He also serves as director of heart transplantation and mechanical circulatory support. Dr. Kilic's areas of clinical expertise include adult cardiac surgery with a special interest in heart transplantation and mechanical circulatory support. Prior to joining Johns Hopkins, Dr. Kilic served as associate professor of surgery at The Ohio State University Wexner Medical Center and was the director of the heart transplant and mechanical circulatory support programs. He was co-director of the advanced heart failure program as well as the vice director of clinical and academic affairs in the division of cardiac surgery. Although a recognized leader in the field of heart failure, Dr. Kilic’s expertise runs the spectrum of cardiac surgery. Dr. Kilic is rated as an Advanced provider by MediFind in the treatment of Heart Tumor. His top areas of expertise are Heart Tumor, Restrictive Cardiomyopathy (RCM), Supravalvular Aortic Stenosis, Heart Transplant, and Heart Bypass Surgery.

Walid Abu Saleh is a primary care provider, practicing in General Practice in Baltimore, Maryland. Dr. Abu Saleh is rated as a Distinguished provider by MediFind in the treatment of Heart Tumor. His top areas of expertise are Heart Tumor, Sinus of Valsalva Aneurysm, Cardiogenic Shock, Thymectomy, and Aortic Valve Replacement.

Manjari Regmi is a Cardiologist in Baltimore, Maryland. Dr. Regmi is rated as an Advanced provider by MediFind in the treatment of Heart Tumor. Her top areas of expertise are Heart Tumor, Mediastinitis, Pulmonary Embolism, and Pericarditis.

Vandana Sachdev is a Cardiologist in Bethesda, Maryland. Dr. Sachdev is rated as an Advanced provider by MediFind in the treatment of Heart Tumor. Her top areas of expertise are Alkaptonuria, Carney Complex, Heart Tumor, Alstrom Syndrome, and Transmyocardial Revascularization.

Anuj Gupta is a Cardiologist in Baltimore,, Maryland. Dr. Gupta is rated as an Advanced provider by MediFind in the treatment of Heart Tumor. His top areas of expertise are Aortic Valve Stenosis, Cardiogenic Shock, Pulmonary Veno-Occlusive Disease, Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Erik Marshall is a Cardiologist in Elkton, Maryland. Dr. Marshall has been practicing medicine for over 42 years and is rated as an Experienced provider by MediFind in the treatment of Heart Tumor. His top areas of expertise are Aortic Valve Stenosis, Dilated Cardiomyopathy (DCM), Cardiomyopathy, Coronary Heart Disease, and Pacemaker Implantation.

Tala K Al-Talib, M.D. is a cardiologist in Baltimore, MD. She is the Medical Director of Johns Hopkins Medicine – Cardiology at Johns Hopkins Greenspring Station. Dr. Al-Talib’s clinical areas of focus are in general and preventative cardiology. She specializes in cardiovascular disease in women, with a particular interest in cardiovascular risk assessment and treatment of cardiac conditions in women with breast cancer or other oncological history. She was integral in the establishment of the Preventative Cardiology Program to Improve Heart Health for Female Breast Cancer Survivors, a collaborative effort to detect asymptomatic cardiovascular disease and ultimately prevent cardiovascular events in this patient group. After receiving her medical degree from University of Maryland School of Medicine, Dr. Al-Talib completed her residency in Internal Medicine at the University of Maryland Medical Center, where she was Chief Medical Resident. She completed her post-doctoral fellowship in cardiovascular medicine at University of Maryland Medical Center. In addition to her clinical practice, Dr. Al-Talib also serves as an inpatient echocardiographer at Bayview Medical Center, performing transesophageal echo (TEE) and cardioversions and attends on the inpatient cardiology services. Videos Red Chair SeriesDr. Tala Al-Talib. Dr. Al is rated as an Experienced provider by MediFind in the treatment of Heart Tumor. Her top areas of expertise are Heart Attack, Doxorubicin-Induced Cardiomyopathy, Cardiomyopathy Due to Anthracyclines, and Apoplexy.

Mark Nelson, MD, specializes in cardiothoracic surgery and is board certified in thoracic and cardiac surgery by the American Board of Thoracic Surgery. He practices at UPMC Heart and Vascular Institute and is affiliated with UPMC Shadyside and UPMC Presbyterian. Dr. Nelson completed his fellowship and residency at West Virginia University School of Medicine and medical education at University of Maryland School of Medicine. Dr. Nelson is rated as an Experienced provider by MediFind in the treatment of Heart Tumor. His top areas of expertise are Thoracic Aortic Aneurysm, Carotid Artery Disease, Abdominal Aortic Aneurysm (AAA), Carotid Artery Surgery, and Heart Bypass Surgery.

James Gammie is the surgical lead and co-director for the Johns Hopkins Heart and Vascular Institute and cardiac surgeon-in-chief for the Johns Hopkins Health System. With over 23 years of experience in cardiothoracic surgery, Dr. Gammie joined Johns Hopkins after serving as chief of the division of cardiac surgery at the University of Maryland Medical Center from 2012 to 2021. Dr. Gammie graduated from Brown University with a degree in biochemistry, and received his medical degree from the University of Massachusetts Medical School. Dr. Gammie trained in both general and cardiothoracic surgery at the University of Pittsburgh School of Medicine. His clinical and research efforts are focused on decreasing the mortality and morbidity of valve disease and improving the surgical treatment of mitral valve and other structural heart diseases. He performs over 225 mitral valve operations and interventions per year, and leads a cardiac surgery team that performs more than 1,200 cardiac operations annually. He is recognized by the Mitral Foundation and the American Heart Association as one of less than 25 reference surgeons in the U.S. for his experience in mitral valve repair and excellent patient outcomes. Dr. Gammie has a strong interest in all aspects of heart valve disease, and has published more than 200 peer-reviewed contributions in leading specialty journals including The New England Journal of Medicine, the Journal of Thoracic and Cardiovascular Surgery and Circulation. He has served as a deputy editor for The Annals of Thoracic Surgery and as chair of the Access and Publications Committee of the Society of Thoracic Surgeons Adult Cardiac Surgery Database. He serves on the steering committee of the NHLBI-sponsored Cardiothoracic Surgery Trials Network, and led the protocol development committee of a worldwide randomized tricuspid valve surgery trial. He is a member of the Halsted Society and the 21st Century Cardiothoracic Surgical Society. In 2011, Dr. Gammie was awarded the Johns Hopkins/University of Maryland Alliance for Science and Technology Development BioMaryland LIFE Prize, and he was named Entrepreneur of the Year at the University of Maryland Baltimore in 2014. He is the inventor of a novel transseptal catheter designed to simplify transcatheter cardiac procedures, and founded a commercial company to commercialize the device. With 20 issued or submitted patents, he continues to innovate in the mitral valve space, and recently published the world’s first clinical experience with a novel surgical repair for secondary mitral valve regurgitation, which was developed in his laboratory: mitral valve translocation. From 2016–2021, Dr. Gammie was consistently named a Top Doctor by Baltimore magazine, and in 2018 he received the Golden Apple Teacher of the Year award. Dr. Gammie is rated as an Experienced provider by MediFind in the treatment of Heart Tumor. His top areas of expertise are Mitral Valve Regurgitation, Tricuspid Regurgitation, Mitral Valve Prolapse, Embolectomy, and Heart Bypass Surgery.

Dr. Richard (Rick) Carrick is a general cardiologist in the Johns Hopkins Division of Medicine and is an assistant professor of medicine at the Johns Hopkins School of Medicine. He also serves as associate director of the Johns Hopkins Hypertrophic Cardiomyopathy Center of Excellence. Originally from Massachusetts, he completed his medical training as well as a Ph.D. in Bioengineering at the University of Vermont and did his internal medicine residency training at Tufts Medical Center in Boston, MA. He completed his Cardiovascular Disease Fellowship and a T32 Research Fellowship at Johns Hopkins. His research focuses on the use of advanced computational techniques like machine-learning and artificial intelligence to improve risk stratification in patients with inherited heart disease. Clinically, he specializes in echocardiography and the care of patients with hypertrophic cardiomyopathy (HCM) and other genetic cardiomyopathies. Dr. Carrick is rated as an Experienced provider by MediFind in the treatment of Heart Tumor. His top areas of expertise are Cardiomyopathy, Hypertrophic Cardiomyopathy (HCM), Ventricular Tachycardia, Arrhythmias, and Cardiac Ablation.

Dr. Zulqarnain Khan joined Cardiovascular Specialists in the summer of 2025. In addition to general cardiology, he trained in sports cardiology, nuclear cardiology, echocardiography, and vascular ultrasound. He completed medical school at the University of Maryland School of Medicine in Baltimore. Dr. Khan went on to complete his internal medicine residency at the University of Maryland Medical Center, where he served as Chief Resident. He completed his cardiology fellowship at the University of Maryland Medical Center, where he participated in the Sports Cardiology track (Johns Hopkins-University of Maryland combined program). Dr. Khan grew up in Catonsville, Maryland. He and his wife, Ishmal, live in Federal Hill with their two children. In his spare time, Dr. Khan is a diehard Ravens and Orioles fan, who also enjoys superhero movies (DC and Marvel). Dr. Khan is rated as an Experienced provider by MediFind in the treatment of Heart Tumor. His top areas of expertise are Atrial Myxoma, Carney Complex, Heart Tumor, and Myocarditis.

Benjamin Barnes is a pediatric cardiologist specializing in fetal cardiology and fetal echocardiography in Baltimore, Maryland. Dr. Barnes was born at The Johns Hopkins Hospital, which is where he also completed his residency in pediatrics and fellowships in pediatric cardiology and pediatric advanced cardiac imaging prior to joining the pediatric cardiology team in 2019. He earned his medical degree from Chicago Medical School. Dr. Barnes is rated as an Experienced provider by MediFind in the treatment of Heart Tumor. His top areas of expertise are Mitral Atresia, Tetralogy of Fallot, Ventricular Septal Defects, and Double Inlet Left Ventricle.

Dr. Michael J. Blaha MD MPH is Professor of Cardiology and Epidemiology and presently serves as the Director of Clinical Research for the Johns Hopkins Ciccarone Center for the Prevention of Cardiovascular Disease, Director of the Cardiometabolic Clinic, and Program Director for the Preventive Cardiology Fellowship. His clinical interests include primary and secondary prevention of cardiovascular disease, with emphasis on early intervention in patients with advanced subclinical atherosclerosis detected with cardiac computed tomography. Dr. Blaha represents the 4th generation of physicians in his family. After earning a BS in pre-medical studies and classical civilization at the University of Notre Dame in 2001, Dr. Blaha went to Vanderbilt University where in 2006 he received his MD as well as an MPH. in clinical epidemiology and biostatistics. Dr. Blaha then completed his Internal Medicine residency in the Osler Medical Housestaff Training Program at Johns Hopkins in 2009 before completing a fellowship in Cardiology at Johns Hopkins in 2012. In 2018, Dr. Blaha received the Dr. Fred Brancati award at Johns Hopkins for excellence in mentoring. He has mentored over 30 trainees, many of which have gone on to hold prominent academic appointments. In 2021, Dr. Blaha was named to the Clarivate Highly Cited Researcher List, representing the top 1% of world’s researchers, and was first named to the Baltimore Magazine Best Doctors List. In 2022, he received the Arthur S. Agatston Cardiovascular Disease Prevention Award. Clinically, he practices as a preventive cardiologist specializing in cardiometabolic disease and in the interpretation of cardiac CT. His clinic specializes in patients with cardiometabolic disease and advanced subclinical atherosclerosis, and the focused use of an array of lifestyle and pharmacotherapies to mitigate that risk. Dr. Blaha is rated as an Experienced provider by MediFind in the treatment of Heart Tumor. His top areas of expertise are Atherosclerosis, Coronary Heart Disease, High Cholesterol, Metabolic Syndrome, and Percutaneous Coronary Intervention (PCI).

Dr. Cingolani is an Associate Professor at The Johns Hopkins University School of Medicine, Division of Cardiology. He earned his medical degree from Universidad Nacional de La Plata, Argentina, and completed his Internship and Internal Medicine Residency at CEMIC, Buenos Aires, Argentina, and hypertension research post-doctoral fellowship at Henry Ford Hospital, Detroit, MI. After completing his Internal Medicine Residency at The Reading Hospital and Medical Center in Pennsylvania, Dr. Cingolani joined The Johns Hopkins Hospital as a Cardiology fellow, where he remained in the Faculty after his training. Currently, he is the Associate Director of The Johns Hopkins Hospital Coronary Care Unit, Director of the Hypertension Center and member of the Echocardiography Lab and Outpatient Cardiology Clinic. He also teaches pathophysiology to medical students. Dr. Cingolani’s research interests focus on hypertensive heart disease and its transition to heart failure. He aims to elucidate the mechanism/s by which certain matricellular proteins present in the heart seem to play a protective role. His research is mainly supported by the National Institute of Health (NIH). He is also the principal investigator of the DREAM study group, studying the effect of Melatonin in preventing atrial fibrillation in patients undergoing cardiac surgery. Dr. Cingolani has been recognized by the Council for High Blood Pressure Research of the American Heart Association for his work in hypertension and is the 2011 recipient of the PJ Schafer Memorial Heart Research Award, the 2012 Michel Mirowski Discovery Fund Award, and 2013 Magic that matters Fund. Dr. Cingolani is rated as an Experienced provider by MediFind in the treatment of Heart Tumor. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Multifocal Atrial Tachycardia, Atrioventricular Nodal Reentrant Tachycardia (AVNRT), Cardiac Ablation, and Tissue Biopsy.

Gayatri Nimmagadda is a Hematologist and a Hematologist Oncology provider in Columbia, Maryland. Dr. Nimmagadda is rated as an Experienced provider by MediFind in the treatment of Heart Tumor. Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Iron Deficiency Anemia, and Pleuropulmonary Blastoma.

Jon R. Resar received his M.D. from the Medical College of Wisconsin in 1985. He completed an internal medicine residency at The Johns Hopkins Hospital and fellowships in cardiovascular medicine and interventional cardiology at The Johns Hopkins Hospital and Johns Hopkins University School of Medicine. He joined the faculty at Johns Hopkins in 1992 and is currently a Professor of Medicine/Cardiology. He was the past Director of the Adult Catheterization Laboratory and Interventional Cardiology at the Johns Hopkins Hospital. His field of specialization is management of coronary artery disease and valvular heart disease. Dr. Resar holds memberships in the American Heart Association and is a Fellow of the American College of Cardiology. Dr. Resar is rated as an Experienced provider by MediFind in the treatment of Heart Tumor. His top areas of expertise are Aortic Valve Stenosis, Heart Attack, Atrial Septal Defect (ASD), Aortic Valve Replacement, and Transcatheter Aortic Valve Replacement (TAVR).

Sabra Lewsey is a cardiologist specializing in heart failure in Baltimore, Maryland. Additionally, she is an assistant professor at the Baltimore-based Johns Hopkins University School of Medicine. Dr. Lewsey earned her medical degree from Columbia University College of Physicians & Surgeons and a master of public health degree from Harvard School of Public Health. She completed her residency in internal medicine at The Johns Hopkins Hospital, where she also completed fellowships in cardiology and advanced heart failure and transplant cardiology. Dr. Lewsey is rated as an Experienced provider by MediFind in the treatment of Heart Tumor. Her top areas of expertise are Heart Failure, Heart Failure with Preserved Ejection Fraction (HFpEF), Cardiomyopathy, Heart Attack, and Heart Transplant.

Dr. Jean Hoffman-Censits is a genitourinary cancer specialist in Baltimore, caring for patients with urothelial cancers of the bladder and upper tract. She serves as co-leader of the Women’s Bladder Cancer Program in the Greenberg Bladder Cancer Institute at the Johns Hopkins University School of Medicine. Dr. Hoffman-Censits received her undergraduate degree in neuroscience from Trinity College. She earned her M.D. degree from the Sidney Kimmel Medical College of Thomas Jefferson University. She completed her residency at Thomas Jefferson University Hospital and performed a fellowship in hematology and oncology at Temple University Medical Center. She joined the Johns Hopkins faculty in 2018. Dr. Hoffman-Censits's research interests focus on urothelial cancers. Her clinical research has helped identify urothelial cancer sub-types and establish new treatments for bladder and upper tract urothelial cancers. She is a member of the American Medical Association, the American Society of Clinical Oncology, the American Urological Association and the Society for Immunotherapy of Cancer. Dr. Hoffman is rated as an Experienced provider by MediFind in the treatment of Heart Tumor. Her top areas of expertise are Urothelial Cancer, Bladder Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Bladder Reconstruction.